Neuroprotection for Parkinson’s disease: a call for clinically driven experimental design. Erwan Bezard The Lancet Neurology. 2003-07-01; 2(7): 393 DOI: 10.1016/s1474-4422(03)00432-0 Auteurs Bordeaux Neurocampus Erwan Bezard
